E-LIB Suche - Ergebnisse für: Schlaepfer, T.E.

1

Diffusion tensor magnetic resonance imaging tractographic a..:

Coenen, V.A. ; Schlaepfer, T.E. ; Bewernick, B....
Brain Stimulation. 10 (2017) 2 - p. 523-524 , 2017

Link: https://doi.org/10.1016/..

2

New imaging technologies paving the road of DBS for psychia..:

Schlaepfer, T.E. ; Barcia, J.A. ; MyIntyre, C.E..
Brain Stimulation. 10 (2017) 2 - p. 456 , 2017

Link: https://doi.org/10.1016/..

3

P.2.b.011 Stable autobiographical memory function in magnet..:

Kayser, S. ; Bewernick, B.H. ; Switala, C...
European Neuropsychopharmacology. 24 (2014) - p. S383-S384 , 2014

Link: https://doi.org/10.1016/..

4

S.03.01 Neuromodulation for treatment of severe and resista..:

Schlaepfer, T.E. ; Coenen, V.A.
European Neuropsychopharmacology. 24 (2014) - p. S53-S54 , 2014

Link: https://doi.org/10.1016/..

5

Magnetic seizure therapy in treatment-resistant depression:..:

Kayser, S. ; Bewernick, B. H. ; Matusch, A....
Psychological Medicine. 45 (2014) 5 - p. 1073-1092 , 2014

Link: https://doi.org/10.1017/..

6

P.2.a.026 Significant clinical, cognitive and imaging findi..:

Kayser, S. ; Bewernick, B.H. ; Hurlemann, R..
European Neuropsychopharmacology. 22 (2012) - p. S239 , 2012

Link: https://doi.org/10.1016/..

7

P.2.a.025 Similar seizure characteristics of electroconvuls..:

Kayser, S. ; Bewernick, B.H. ; Hurlemann, R..
European Neuropsychopharmacology. 22 (2012) - p. S238-S239 , 2012

Link: https://doi.org/10.1016/..

8

P.2.e.014 Effects of magnetic seizure therapy in patients w..:

Kayser, S. ; Bewernick, B.H. ; Lenz, D....
European Neuropsychopharmacology. 21 (2011) - p. S425-S426 , 2011

Link: https://doi.org/10.1016/..

9

Clinical milestones predict symptom remission over 6-month ..:

Wade, A.G. ; Schlaepfer, T.E. ; Andersen, H.F..
Journal of Psychiatric Research. 43 (2009) 5 - p. 568-575 , 2009

Link: https://doi.org/10.1016/..

10

S.02.05 Deep brain stimulation for treatment resistant depr..:

Schlaepfer, T.E. ; Bewernick, H.E. ; Kayser, S...
European Neuropsychopharmacology. 19 (2009) - p. S178 , 2009

Link: https://doi.org/10.1016/..

11

P.2.a.002 Treatment milestones predict symptom remission ov..:

Wade, A. ; Schlaepfer, T.E. ; Kilts, C.D.
European Neuropsychopharmacology. 18 (2008) - p. S293-S294 , 2008

Link: https://doi.org/10.1016/..

12

Vagus nerve stimulation for depression: efficacy and safety..:

Schlaepfer, T. E. ; Frick, C. ; Zobel, A....
Psychological Medicine. 38 (2008) 5 - p. 651-661 , 2008

Link: https://doi.org/10.1017/..

13

Repetitive transcranial magnetic stimulation (rTMS) and mag..:

Schlaepfer, T.E. ; Frick, C. ; Kayser, S.
Journal of Affective Disorders. 107 (2008) - p. S21-S22 , 2008

Link: https://doi.org/10.1016/..

14

P.2.a.003 Baseline severity of depression predicts antidepr..:

Wade, A.G. ; Kilts, C.D. ; Schlaepfer, T.E.
European Neuropsychopharmacology. 18 (2008) - p. S294 , 2008

Link: https://doi.org/10.1016/..

15

Non-Pharmacological Approaches to the Treatment of Depressi..:

, In: Proceedings of the Medtronic Forum for Neuroscience and Neuro-Technology 2005,

Schlaepfer, T. E. - p. 54-56 , 2007

Link: https://doi.org/10.1007/..